Clinical Practice Gudielines
These guidelines will offer recommendations for diagnosing and staging diabetic kidney disease. They will define the prevalence, frequency and severity of CKD-specific complications in diabetic kidney disease, describe treatment approaches and propose research areas where data is lacking. The work group has convened two meetings and the guidelines will be published in 2005.
Work Group and Evidence Review Team Membership
Chairs:
Robert Nelson, MD
National Institutes of Health
Phoenix, AZ
Katherine Tuttle, MD
The Heart Research Institute
Spokane, WA
Work Group:
Pablo Ascher, MD
George L. Bakris, MD
Rudy Bilous, MD
Michelle M. Chapman, PharmD, BCPS
D. Jordi Goldstein, DSc, RD
S. Michael Mauer, MD
Mark Molitch, MD
Andrew Narva, MD
Marc Pfeffer, MD
Mary Ann Sevick, ScD, RN
Michael Shlipak, MD
Christoph Wanner, MD
Liaisons:
Jeffrey Cutter, MD, MPH
National Heart, Lung and Blood Institute (NHLBI)
Bethesda, MD
Tom Hostetter, MD
National Institutes of Diabetes and Digestive and Kidney Diseases
Bethesda, MD
Evidence Review Team:
Joseph Lau, MD
Ethan Balk, MD
George Fares
Katrin Uhlig, MD
New England Medical Center
Boston, MA
